Adenoid cystic carcinoma of the breast: A tumour commonly devoid of oestrogen receptors and related proteins

Histopathology

Volumn 35, Issue 3, 1999, Pages 241-248

  Trendell Smith, N J ^a   Peston, D ^a   Shousha, S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Adenoid cystic carcinoma; Breast; Invasive cribriform carcinoma; Oestrogen receptors; Progesterone receptors

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROLACTIN RECEPTOR; PROTEIN P27;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CRIBRIFORM CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, ADENOID CYSTIC; CELL CYCLE; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032882911     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00722.x     Document Type: Article

References (31)

1. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. London: Churchill Livingstone, 1987; 193-243.
2. Azzopardi JG. Problems in Breast Pathology. London: W B Saunders, 1979; 335-339.
3. Fisher ER, Gregorio RM, Fisher B. The pathology of invasive breast cancer. A syllabus derived from lindings of the National Surgical Adjuvant Breast Project (Protocol no. 4). Cancer 1975; 36; 1-85.
4. Seifert G, Sobin LH. The World Health Organization's histological classification of salivary gland tumors. A commentary on the 2nd edn. Cancer 1992; 70; 379-385.
5. Anthony PP, Jumes PD. Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and hitogenesis. J. Clin. Pathol. 1975; 28; 647-655.
6. Zaloudek C, Oertel YC, Orenstein JM. Adenoid cystic carcinoma of the breast. Am. J. Clin. Pathol. 1984; 81; 297-307.
7. Sumpio BE, Jennings TA, Sullivan PD, Merino MJ. Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann. Surg. l987; 205; 295-301.
8. Peters GN, Wolff M. Adenoid cystic carcinoma of the breast. Report of 11 new cases: review of the literature and discussion of biological behaviour. Cancer 1982; 52; 680-686.
9. Leeming R, Jenkins M, Mendelsohn G. Adenoid cystic carcinoma of the breast. Arch. Surg. 1992; 127; 233-235.
10. Pastolero G, Hanna W, Zbieranowski I, Kahn HJ. Prolitferative activity and p53 expression in adenoid cystic carcinoma of the breast. Mod. Pathol. 1996; 9; 215-219.
11. Kleer CG, Obermun HA. Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity. Am. J. Surg. Pathol. 1998; 22; 569-575.
12. Herzberg AJ, Bossen EH, Walther PJ. Adenoid cystic carcinoma of the breast metastatic to the kidney. A clinically symptomatic lesion requiring surgical treatment. Cancer 1991; 68; 1015-1020.
13. Wells CA, Nicoll S, Ferguson DJP. Adenoid cystic carcinoma of the breast: a case with oxillary lymph node metastasis. Histopathology 1986; 10; 415-424.
14. Venable JG, Schwartz AM. Silverberg SG. Invasive cribriform carcinoma of the breast: a distinctive clinicopathological entity. Human Pathol. 1990; 21; 333-338.
15. Page DL, Dixon JM, Anderson TJ, Lee D, Stewart HJ. Invasive cribriform carcinoma of the breast. Histopathology 1983; 7; 525-536.
16. Shousha S, Peston D. Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinomas. Curr. Diag. Pathol. 1997; 4; 176-181.
17. Kasami M, Olson SJ, Simpson JF, Page DL. Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study. Histopathology 1998; 32; 232-238.
18. Due W, Herbst H, Loy V, Stein H. Characterisation of adenoid cystic carcinoma of the breast by immunohistology. J. Clin. Pathol. 1989; 42; 470-476.
19. Kern WH. Morphological and clinical aspects of oestrogen receptors in carcinoma of the breast. Surg. Gynaecol. Obstet. 1979; 148; 240-242.
20. Soubeyran I, Wafflart J, Bonichon F et al. Immunohistochemical determination of pS2 in invasive carcinoma: a study on 942 cases. Breast Cancer Res. Treat. 1995; 34; 119-128.
21. Clevenger CV, Chang WP, Ngo W, Pasha TLM, Montone KT, Tomaszewski JE. Expression of prolactin and prolactin receptor in human breast carcinoma - evidence of an autocrine/paracrine loop. Am. J. Pathol. 1995; 146; 695-705.
22. Nixon AJ, Schnitt SJ, Gelman R et al. Relationship of tumor grade to other pathologic features and to treatment outcome patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 1996; 78; 1426-1433.
23. Foschini MP, Eusebi V, Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch. 1998; 432; 303-310.
24. Van Dorpe J, De Pauw A, Moerman P. Adenoid cystic carcinoma arising in an adenomyoepithelioma of the breast. Virchows Arch. 1998; 432; 119-122.
25. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am. J. Surg. Pathol. 1987; 11; 918-929.
26. Chhieng C, Cranor M, Lesser ME, Kosen PP. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am. J. Surg. Pathol. 1998; 22; 188-194.
27. Rosen PP, Cranor ML. Secretory carcinoma of the breast. Arch. Pathol. Lab. Med. 1991; 115; 141-144.
28. Ciocco DR, Fujimura FK, Tandon AKet al. Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J. Nat. Cancer Inst. 1992; 84; 1279-1282.
29. Veronese SM, Gambacorta M. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features. Am. J. Clin. Pathol. 1991; 95; 30-34.
30. Elledge RM, Allred C. The p53 tumor suppressor gene in breast cancer. Breast Cancer Res. Treat. 1994; 32; 39-47.
31. Catzavelos C, Bhattacharya N, Ung YC et al. Decreased levels of the cell-cycle inhibitor p27kip1 protein: prognostic implications in primary breast cancer. Nature Med. 1997; 3; 227-230.